T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global Alliance Global Partners analyst Ben Haynor raised the firm's price target on T2 Biosystems to $2.60 from $1.65 and reiterates a Buy rating on the shares following the company's Q3 results.